Cidara Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 73
Rang # Quantité totale PI 18 336
Note d'activité PI 2,6/5.0    52
Rang # Activité PI 14 034
Symbole boursier
ISIN US1717571079
Capitalisation 259M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

10 7
12 1
40 0
3
 
Dernier brevet 2024 - Methods for treating influenza i...
Premier brevet 2012 - Antifungal agents and uses thereof
Dernière marque 2024 - CLOUDBREAK
Première marque 2014 - CLOUDBREAK

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the prevention and treatment of infectious diseases and disorders...
P/S Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment or preve...
Invention Methods for treating influenza infections. Provided herein are methods for inhibiting, reducing, ...
2023 P/S Pharmaceutical research and development; research and development of biological and pharmaceutica...
Invention Compositions and methods for the treatment of viral infections. Compositions and methods for the...
Invention Fc conjugates including an inhibitor of cd73 and uses thereof. The disclosure provides conjugates...
2022 Invention Single dose methods for preventing and treating fungal infections. Provided herein are methods f...
Invention Protein-drug conjugates for antiviral therapy. Compositions and methods for the treatment of vir...
Invention Protein-drug conjugates for antiviral therapy. Compositions and methods for the treatment of vira...
Invention Variant fc domains and uses thereof. This disclosure relates to variant Fc domain monomers, fusi...
Invention Variant fc domains and uses thereof. This disclosure relates to variant Fc domain monomers, fusio...
2021 Invention Compositions and methods for the treatment of human immunodeficiency virus. Compositions and meth...
Invention Methods for the synthesis of protein-drug conjugates. The present invention relates to methods f...
Invention Methods for the synthesis of protein-drug conjugates. The present invention relates to intermedi...
Invention Methods for the synthesis of protein-drug conjugates. The present invention relates to methods fo...
Invention Methods for the synthesis of protein-drug conjugates. The present invention relates to intermedia...
Invention Compositions and methods for the treatment of viral infections. Compositions and methods for the ...
2020 Invention Compositions and methods for the treatment of human immunodeficiency virus. This disclosure relat...
Invention Compositions and methods for the treatment of respiratory syncytial virus. Compositions and metho...
Invention Compositions and methods for the treatment of viral infections. e.ge.ge.g., influenza viral infec...
Invention Compositions and methods for the treatment of human immunodeficiency virus. Compositions and met...
Invention Compositions and methods for the treatment of respiratory syncytial virus. Compositions and meth...
P/S Pharmaceutical and biological preparations to prevent and treat fungal infections and diseases
2019 Invention Polymorph of echinocandin antifungal agent. The present invention relates to crystalline polymorp...
Invention Compositions and methods for the treatment of bacterial infectons. Compositions and methods for t...
Invention Compositions and methods for the treatment of bacterial infections. Compositions and methods for ...
Invention Synthesis of echinocandin antifungal agent. The present invention relates to echinocandin cyclope...
2018 Invention Methods for treating fungal infections. The invention relates to methods of treating dermatophyt...
Invention Methods for preventing and treating intra-abdominal candidiasis. Provided herein are methods of ...
Invention Methods for preventing and treating intra-abdominal candidiasis. Provided herein are methods of i...
2017 Invention Compositions and methods for the treatment of bacterial infections. Compositions and methods for...
Invention Methods for preventing fungal infections. Provided herein are methods for preventing or reducing...
2016 P/S Pharmaceutical compounds.
P/S Pharmaceutical compounds for the treatment and prevention of infectious diseases, namely bacteria...
2015 P/S Pharmaceutical compounds for the treatment or prevention of infectious diseases
2014 P/S Research and development in the field of antifungal compounds.
P/S Pharmaceutical preparations for the treatment or prevention of infectious diseases